Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Young Mi | - |
dc.contributor.author | Seo, Hyun Joo | - |
dc.contributor.author | Choi, Seo Heui | - |
dc.contributor.author | Jung, Yu Jin | - |
dc.contributor.author | Ahn, So Yoon | - |
dc.contributor.author | Yoo, Hye Soo | - |
dc.contributor.author | Sung, Se In | - |
dc.contributor.author | Shim, Jae Won | - |
dc.contributor.author | Lee, Yeon Kyung | - |
dc.contributor.author | Ko, Sun Young | - |
dc.contributor.author | Shin, Son Moon | - |
dc.contributor.author | Hwang, Jong Hee | - |
dc.contributor.author | Lee, Jang Hoon | - |
dc.contributor.author | Choi, Byung Min | - |
dc.contributor.author | Kim, Eun Sun | - |
dc.contributor.author | Jeon, Ji Hyun | - |
dc.contributor.author | Kim, Sung Shin | - |
dc.contributor.author | Chang, Yun Sil | - |
dc.contributor.author | Park, Won Soon | - |
dc.date.accessioned | 2021-09-04T14:49:52Z | - |
dc.date.available | 2021-09-04T14:49:52Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2015-07 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93158 | - |
dc.description.abstract | The aim of this study was to observe the effects of prophylactic palivizumab on hospitalization secondary to respiratory syncytial virus (RSV) infection (RSVhospitalization) in former very low birth weight infants (VLBWI) with bronchopulmonary dysplasia (BPD). This study also sought to identify the risk factors of RSVhospitalizationin this particular infant population. A prospective observational study was conducted between September 2007 and April 2008 in seven Korean hospitals. Children with a history of very low birth weight, a diagnosis of BPD and who were < 2 yr old at the onset of the RSV season were included in this study. Palivizumab injections were administered monthly for a maximum of five months during the RSV season. RSVhospitalization rates were reviewed, and RSVhospitalization rates between subgroups were categorized by gestational age, birth weight, and duration of ventilator care. A total of 90 subjects completed the follow- up interviews. The mean gestational age at birth was 26.1 +/- 1.7 weeks, and the mean birth weight was 889.4 +/- 222.2 g. The incidence of RSVhospitalization in the study population was 8.9% (8/90), and the mean hospital stay was 11.0 +/- 5.5 days, including one death. There were no statistically significant differences in the patients' demographic characteristics or risk factors for RSV hospitalization. When subgroup analyses were conducted, there were still no statistically significant differences. The administration of palivizumab prophylaxis during the entire RSV season is important in VLBWI with BPD, regardless of their gestational age and birth weight, or previous ventilator dependency. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | RE-HOSPITALIZATION | - |
dc.subject | MONOCLONAL-ANTIBODY | - |
dc.subject | 1ST YEAR | - |
dc.subject | OUTCOMES | - |
dc.subject | PREVENTION | - |
dc.subject | CHILDREN | - |
dc.subject | DISEASE | - |
dc.subject | KOREA | - |
dc.subject | LESS | - |
dc.subject | LIFE | - |
dc.title | Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Byung Min | - |
dc.identifier.doi | 10.3346/jkms.2015.30.7.924 | - |
dc.identifier.scopusid | 2-s2.0-84951772545 | - |
dc.identifier.wosid | 000361312000015 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.30, no.7, pp.924 - 931 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 30 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 924 | - |
dc.citation.endPage | 931 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002011360 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | RE-HOSPITALIZATION | - |
dc.subject.keywordPlus | MONOCLONAL-ANTIBODY | - |
dc.subject.keywordPlus | 1ST YEAR | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | KOREA | - |
dc.subject.keywordPlus | LESS | - |
dc.subject.keywordPlus | LIFE | - |
dc.subject.keywordAuthor | Respiratory Syncytial Viruses | - |
dc.subject.keywordAuthor | Palivizumab | - |
dc.subject.keywordAuthor | Hospitalization | - |
dc.subject.keywordAuthor | Bronchopulmonary Dysplasia | - |
dc.subject.keywordAuthor | Preterm | - |
dc.subject.keywordAuthor | Infant | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.